A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
© 2015 Luangchosiri et al. Background: Hepatitis is a common adverse effect of antituberculosis drugs. Silymarin prevented drug-induced hepatoxicity in animals with anti-oxidative mechanisms but its effect in human has been unknown. We aimed to evaluate the efficacy of silymarin for preventing antit...
Saved in:
Main Authors: | Chote Luangchosiri, Ammarin Thakkinstian, Sermsiri Chitphuk, Wasana Stitchantrakul, Supanna Petraksa, Abhasnee Sobhonslidsuk |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/36321 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
by: Chote Luangchosiri, et al.
Published: (2017) -
Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
by: Jamrus Pongpit, et al.
Published: (2018) -
Non-alcoholic Fatty Liver Disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes
by: Abhasnee Sobhonslidsuk, et al.
Published: (2018) -
Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: A systematic review and meta-analysis
by: Lancharat Chuncharunee, et al.
Published: (2020) -
Mitochondrial DNA content as a diagnostic marker for antituberculosis drug-induced liver injury
by: Udomsinprasert W.
Published: (2023)